HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Lichtenstein Selected Research

Interleukin-2 (IL2)

6/2009Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Lichtenstein Research Topics

Disease

1Skin Neoplasms (Skin Cancer)
06/2016
1Neoplasms (Cancer)
06/2016
1Crohn Disease (Crohn's Disease)
06/2009
1Necrosis
06/2009
1Colitis
06/2009

Drug/Important Bio-Agent (IBA)

1Dextrans (Dextran)FDA Link
06/2009
1Interleukin-2 (IL2)IBA
06/2009
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
06/2009
1Phosphates (Orthophosphate)IBA
06/2009
1Proteins (Proteins, Gene)FDA Link
06/2009
1Messenger RNA (mRNA)IBA
06/2009
1Interleukin-2 Receptors (IL 2 Receptor)IBA
06/2009

Therapy/Procedure

1Mohs Surgery (Mohs' Micrographic Surgery)
06/2016
1Injections
06/2009
1Aftercare (After-Treatment)
06/2009